Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality, with advanced disease resistant to conventional therapies. Targeted combined immunotherapy, such as ICIs with TKIs or anti-VEGF agents, has improved outcomes, but heterogeneous responses ne... ...

请注册登录后继续浏览